Skip to content

Right Ventricular Function in Heart Failure

Assessment Right Ventricular Systolic Function in Heart Failure With Preserved, Reduced and Mid-range Ejection Fraction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03641599
Enrollment
150
Registered
2018-08-22
Start date
2017-01-01
Completion date
2018-07-01
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assessment of the RV Function in Patients With Heart Faliure

Keywords

RV systolic function, HFpEF, HFmrEF, HFrEF

Brief summary

Only a few studies evaluated the RV systolic function in the three categories of HF, regarding the importance of understanding changes in RV function on clinical presentation and outcome; it was essential to understand the prevalence and severity of RV dysfunction among the three groups and the degree of correlation between RV with LV systolic function.

Interventions

DIAGNOSTIC_TESTechocardiography

echocardiographic assessment of the RV and LV systolic function

Sponsors

shaimaa Mostafa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Adult patients of both gender who have the followiong criteria : (i) symptoms with or without signs of HF (ii) elevated natriuretic peptides (BNP ≥35pg/ mL or NT-proBNP≥125pg/mL) (iii) relevant structural heart disease: left ventricle hypertrophy (left ventricular mass index ≥115 g/m2 for males and ≥95 g/m2 for females) or left atrial enlargement (\>34 mL/m2) or diastolic dysfunction (E/e'≥13 and a mean e' septal and lateral wall \<9 cm/s) were included. Then patients were classified according to EF into HFpEF\>50%, HFrEF\<40% and HFmrEF \>40% and \<50%

Exclusion criteria

Patients with chronic obstructive pulmonary disease history of pulmonary embolism patients with respiratory failure

Design outcomes

Primary

MeasureTime frameDescription
assessment of the RV systolic dysfunction in patients with heart failure1.5 yeardegree and prevalence of the RV systolic dysfunction in patients with heart failure with preserved, mid-range and decreased ejection fraction

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026